4
Changes in Ownership
Allogene Therapeutics, Inc. Filed Acc 0001214659-20-005383
Director bought 146,382 shares at $47.00 ($6,879,954)
From the SEC's structured data for this filing
Trades in this filing
Belldegrun Arie · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-06-04 | Purchase : show line 1 in the form | +40,000 | $47.00 | $1,880,000 | 40,000 | I |
| 2020-06-04 | Purchase : show line 2 in the form | +106,382 | $47.00 | $4,999,954 | 1,798,163 | I |
| Open-market purchases · 146,382 sh · avg $47.00 · $6,879,954 | ||||||
Loading xslF345X03/marketforms-48964.xml…